Polen Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-696
Closed -$391K 257
2025
Q4
$391K Sell
696
-96
-12% -$54.5K ﹤0.01% 197
2025
Q3
$407K Sell
792
-3,816
-83% -$1.67M ﹤0.01% 201
2025
Q2
$1.45M Sell
4,608
-19,858
-81% -$5.96M ﹤0.01% 108
2025
Q1
$7.45M Buy
24,466
+8,243
+51% +$2.77M 0.02% 47
2024
Q4
$5.39M Buy
16,223
+1,259
+8% +$427K 0.01% 66
2024
Q3
$5M Sell
14,964
-2,377
-14% -$903K 0.01% 62
2024
Q2
$7.14M Buy
17,341
+382
+2% +$151K 0.02% 56
2024
Q1
$6.85M Buy
16,959
+89
+0.5% +$31.3K 0.02% 58
2023
Q4
$5.17M Buy
+16,870
New +$4.55M 0.01% 77
2022
Q2
Sell
-4,555
Closed -$745K 91
2022
Q1
$745K Sell
4,555
-113,670
-96% -$18.7M ﹤0.01% 85
2021
Q4
$25.7M Buy
118,225
+23,703
+25% +$4.96M 0.04% 43
2021
Q3
$17.9M Buy
94,522
+7,111
+8% +$1.3M 0.03% 43
2021
Q2
$15.4M Buy
87,411
+5,463
+7% +$943K 0.03% 46
2021
Q1
$13.4M Buy
81,948
+14,292
+21% +$2.19M 0.03% 40
2020
Q4
$9.42M Buy
67,656
+34,057
+101% +$4.29M 0.02% 46
2020
Q3
$3.75M Buy
33,599
+5,225
+18% +$604K 0.01% 58
2020
Q2
$2.64M Buy
+28,374
New +$2.41M 0.01% 54

Other funds holding MEDP

Polen Capital Management's MEDP Position: Q1 2026 in Review

Polen Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 696 shares — an estimated $391K sold.

Polen Capital Management first reported a position in MEDP in Q2 2020 and held it in 17 quarters. The position peaked at $25.7M in Q4 2021. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Polen Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Polen Capital Management sold 696 Medpace shares in Q1 2026, an estimated $391K.
  • Polen Capital Management first reported a position in Medpace in Q2 2020 and held it in 17 quarters.
  • Polen Capital Management's Medpace position peaked at $25.7M in Q4 2021.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Polen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.